Matches in Nanopublications for { ?s ?p "[Thus, human resistin is a novel therapeutic target for mitigating common hepatic pathophysiological processes associated with human obesity, dyslipidemia and atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP759537.RAUrGEhQS-6PvNztJYx4vMIWf5qivBZrCqCNjEBsygWsY130_assertion description "[Thus, human resistin is a novel therapeutic target for mitigating common hepatic pathophysiological processes associated with human obesity, dyslipidemia and atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759537.RAUrGEhQS-6PvNztJYx4vMIWf5qivBZrCqCNjEBsygWsY130_provenance.
- NP798981.RA_iPotfRqDQJGvvqbcP6cDg6sPm66bYel_22swwgzGk0130_assertion description "[Thus, human resistin is a novel therapeutic target for mitigating common hepatic pathophysiological processes associated with human obesity, dyslipidemia and atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP798981.RA_iPotfRqDQJGvvqbcP6cDg6sPm66bYel_22swwgzGk0130_provenance.
- NP924016.RAQIw_Er8Q1hyD1ZmcnvAdxR2KKaNr1Jlsb3MrUeLKTgY130_assertion description "[Thus, human resistin is a novel therapeutic target for mitigating common hepatic pathophysiological processes associated with human obesity, dyslipidemia and atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924016.RAQIw_Er8Q1hyD1ZmcnvAdxR2KKaNr1Jlsb3MrUeLKTgY130_provenance.
- NP870112.RAZef59LDpUMi734RypMu13FtV6tmz0uSHyiO5-hNCS0w130_assertion description "[Thus, human resistin is a novel therapeutic target for mitigating common hepatic pathophysiological processes associated with human obesity, dyslipidemia and atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870112.RAZef59LDpUMi734RypMu13FtV6tmz0uSHyiO5-hNCS0w130_provenance.
- NP870113.RAYFsYXIWRgxdwCG2V9zNdwqB0R2Yn_pXVa5q7y6sAcuU130_assertion description "[Thus, human resistin is a novel therapeutic target for mitigating common hepatic pathophysiological processes associated with human obesity, dyslipidemia and atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870113.RAYFsYXIWRgxdwCG2V9zNdwqB0R2Yn_pXVa5q7y6sAcuU130_provenance.
- NP870114.RAXZGtItX1OPs9ji8itYXSTytV0bcsSTgK9a6p0gTKccg130_assertion description "[Thus, human resistin is a novel therapeutic target for mitigating common hepatic pathophysiological processes associated with human obesity, dyslipidemia and atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870114.RAXZGtItX1OPs9ji8itYXSTytV0bcsSTgK9a6p0gTKccg130_provenance.
- assertion description "[Thus, human resistin is a novel therapeutic target for mitigating common hepatic pathophysiological processes associated with human obesity, dyslipidemia and atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Thus, human resistin is a novel therapeutic target for mitigating common hepatic pathophysiological processes associated with human obesity, dyslipidemia and atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Thus, human resistin is a novel therapeutic target for mitigating common hepatic pathophysiological processes associated with human obesity, dyslipidemia and atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Thus, human resistin is a novel therapeutic target for mitigating common hepatic pathophysiological processes associated with human obesity, dyslipidemia and atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP924031.RAm07bmX4hzH3DS2T7Hfz8x5puohG2vr7hSPzr5iVJB4Q130_assertion description "[Thus, human resistin is a novel therapeutic target for mitigating common hepatic pathophysiological processes associated with human obesity, dyslipidemia and atherosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924031.RAm07bmX4hzH3DS2T7Hfz8x5puohG2vr7hSPzr5iVJB4Q130_provenance.